MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Nov. 6, 2020-- Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the following upcoming investor conferences: Peter Kuipers , Omnicell...
GAAP and non-GAAP revenues of $213.7 million GAAP net income per diluted share of $0.20 Non-GAAP net income per diluted share of $0.60 MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Oct. 27, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for...
Expands pharmacy inventory management capabilities for efficient, compliant management of 340B programs Accelerates Omnicell’s strategic transformation to support the vision of the fully Autonomous Pharmacy , building on the recent launch of Omnicell One Expected to be immediately accretive to...
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Sep. 29, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Tuesday, October 27, 2020 , to discuss the Company’s Third Quarter...
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Sep. 23, 2020-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced today the pricing of $500 million aggregate principal amount of 0.25% Convertible Senior...
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Sep. 22, 2020-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that it intends to offer, subject to market conditions and other factors, $500.0...
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Sep. 1, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will present at the following upcoming investor conferences: 2020 Wells Fargo Virtual Healthcare...
Expands pharmacy supply chain capabilities for efficient, compliant management of 340B programs Accelerates Omnicell’s strategic transformation to support the vision of the fully Autonomous Pharmacy , building on the recent launch of Omnicell One Expected to be immediately accretive to non-GAAP...
GAAP revenues of $199.6 million and net loss per diluted share of $0.10 Non-GAAP revenues $199.6 million and net income per diluted share of $0.37 Omnicell’s Response to Coronavirus (COVID-19) MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Jul. 28, 2020-- Omnicell, Inc....
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Jul. 21, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Tuesday, July 28, 2020 , to discuss the Company’s Second Quarter...
